Divisions

This facility will manufacture devices with InSitu's patented stent design and proprietary stent manufacturing technologies.  The devices include; Siro™ drug eluting stent, Celosia™ covered stent, and Silene™ Peripheral covered stent.  These devices will support both domestic patient needs and support international export markets. Pakistan currently relies heavily on imported stents to meet local demand (400k stents annually), and this initiative is designed to change that, while opening the door for Pakistan to become a source of high quality, internationally trusted stent technology manufacturing facility.

With over 30 years of cardiovascular device engineering and U.S. regulatory pathway experience, InSitu is bringing proven technology, quality systems, and manufacturing expertise to a purpose built facility in Rawalpindi, now under development. The project is moving forward with a clear pathway toward ISO 13485 certification and DRAP manufacturing licensing and FDA registered establishment, and will draw on InSitu's existing distributor network across more than 48 countries as it expands internationally.

We believe this facility will strengthen Pakistan's healthcare manufacturing base, reduce reliance on imported medical devices, and create new opportunities for growth and innovation in the region.